CONSISTENCY OF FRIEDEWALD, MARTIN/HOPKINS AND SAMSON FORMULAS FOR LDL-C CALCULATION IN HIGH AND VERY HIGH CARDIOVASCULAR RISK PATIENTS

被引：0
|
作者：
Basaran, O. [1 ]
Dogan, V. [1 ]
Celik, O. [1 ]
Cil, C. [2 ]
Ozlek, B. [2 ]
Ozlek, E. [2 ]
Ozdemir, I. H. [3 ]
Rencuzogullari, I. [4 ]
Karadeniz, F. [5 ]
Tekinalp, M. [6 ]
Askin, L. [7 ]
Demirelli, S. [5 ]
Gencer, E. [8 ]
Biteker, M. [1 ]
Kayikcioglu, M. [9 ]
机构：
[1] Mugla Sitki Kocman Univ, Cardiol, Mugla, Turkey
[2] Mugla Sitki Kocman Univ Educ & Res Hosp, Cardiol, Mugla, Turkey
[3] Nizip State Hosp, Cardiol, Gaziantep, Turkey
[4] Kars Univ, Cardiol, Kars, Turkey
[5] Erzurum Educ & Res Hosp, Cardiol, Erzurum, Turkey
[6] Necip Fazil State Hosp, Cardiol, Kahramanmaras, Turkey
[7] Adiyaman Univ, Cardiol, Adiyaman, Turkey
[8] Kilis State Hosp, Cardiol, Kilis, Turkey
[9] Ege Univ, Cardiol, Sch Med, Izmir, Turkey
来源：
ATHEROSCLEROSIS | 2022年 / 355卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP231
引用
收藏
页码：E160 / E160
页数：1
相关论文
共 50 条
  • [41] LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) VALUES AMONG HIGH CARDIOVASCULAR RISK PATIENTS IN A REAL WORLD POPULATION
    Punekar, Rajeshwari S.
    Fox, Kathleen
    Richhariya, Akshara
    Gandra, Shravanthi
    Cziraky, Mark
    Paoli, Carly
    Toth, Peter
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 2034 - 2034
  • [42] THE REAL EXPERIENCE OF REACHING AN EXTREMELY LOW LDL-C LEVEL IN HIGH RISK PATIENTS
    Korneva, V. A.
    Kuznetsova, T.
    ATHEROSCLEROSIS, 2022, 355 : E175 - E175
  • [43] INFLUENCE OF EXTREME HIGH DENSITY LIPOPROTEIN CHOLESTEROL (HDL-C) VALUES ON THE CALCULATION OF LOW DENSITY LIPOPROTEIN CHOLESTEROL (LDL-C) USING FRIEDEWALD FORMULA
    Timon-Zapat, J.
    Laserna-Mendieta, E. J.
    Pineda-Tenor, D.
    Cabezas-Martinez, M. A.
    Gomez-Serranillos, M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S345 - S345
  • [44] Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c
    Hajer, G. R.
    van der Graaf, Y.
    Bots, M. L.
    Algra, A.
    Visseren, F. L. J.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (08) : 680 - 688
  • [45] Atorvastatin Therapy in Practice- LDL Values in Patients with very high Cardiovascular Risk
    Laufs, Ulrich
    Jannowitz, Christina
    Pittrow, David
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2017, 142 (16) : 1249 - 1252
  • [46] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
    Ulrich Laufs
    Barbara Karmann
    David Pittrow
    Clinical Research in Cardiology, 2016, 105 : 783 - 790
  • [47] FAVOURABLE IMPACT ON LIPID LEVELS OF INCREASING STATIN DOSE IN HIGH-RISK PATIENTS WITH VERY HIGH BASELINE LDL-C: RESULTS FROM VOYAGER
    Lundman, P.
    Palmer, M. K.
    Karlson, B. W.
    Barter, P. J.
    Nicholls, S. J.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 164 - 164
  • [48] Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk
    Laufs, Ulrich
    Karmann, Barbara
    Pittrow, David
    CLINICAL RESEARCH IN CARDIOLOGY, 2016, 105 (09) : 783 - 790
  • [49] THE CHALLENGE OF LIPID-MODIFYING THERAPIES IN THE ACHIEVEMENT OF OPTIMAL LDL-C LEVELS IN HIGH AND VERY HIGH CV RISK PATIENTS: STILL AN OPEN QUESTION
    Rossi, I.
    D'Ardes, D.
    Bucciarelli, B.
    Bianco, F.
    Troiano, F.
    Vizzarri, P.
    Caporale, M.
    Cipollone, F.
    Bucci, M.
    ATHEROSCLEROSIS, 2022, 355 : E306 - E306
  • [50] Should patients with high cardiovascular risk and an LDL-C concentration below 70 mg/dl be treated with aggressive statin therapy?
    Lee, Cheol Whan
    Park, Seung-Jung
    CLINICAL LIPIDOLOGY, 2012, 7 (01) : 1 - 4
12345